[Non-Hodgkin's lymphomas in patients with human immunodeficiency virus infections. Clinicopathologic characteristics, treatment response and prognosis in 40 patients].
Josep‐María Ribera(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona), Albert Oriol(Institut Català d'Oncologia), Fuensanta Millá, Artigas Raventós, A. Flores, M Vaquero, G. Sirera(Hospital Universitari Germans Trias i Pujol), José‐Tomás Navarro(Universitat Autònoma de Barcelona)
PubMed
December 1, 1994
Cited by 1
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719